Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2
Kuan-Ying A. Huang, Xiaorui Chen, Arpita Mohapatra, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 15
Broadly neutralizing antibodies against COVID-19
Daming Zhou, Jingshan Ren, Elizabeth E. Fry, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101332-101332
Open Access | Times Cited: 19
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with Escherichia coli
Shuai Zhao, Wanting Zeng, Fang Yu, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 111-111
Open Access
Epitope-focused vaccine immunogens design using tailored horseshoe-shaped scaffold
Fangxin Zhao, Yue Zhang, Zhiling Zhang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Molecular mechanistic exploration of conformational shifts induced by class IV anti-RBD antibody IY2A
Enhao Zhang, Song Luo, Xiaole Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 141417-141417
Closed Access
Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study
Masaya Fujitani, Xiuyuan Lu, Ryo Shinnakasu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants
Shuo Liu, Pan Liu, Qiong Lu, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Open Access
Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation
Zhaohui Cai, Raj Kalkeri, Mingzhu Zhu, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 501-501
Open Access | Times Cited: 4
An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
Banghui Liu, Xuefeng Niu, Yijun Deng, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114265-114265
Open Access | Times Cited: 3
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012246-e1012246
Open Access | Times Cited: 2
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants
Qihong Yan, Xijie Gao, Banghui Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Mechanistic study of the transmission pattern of the SARS‐CoV‐2 omicron variant
Ke An, Xianzhi Yang, Mengqi Luo, et al.
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 6, pp. 705-719
Open Access | Times Cited: 1
A SARS-CoV-2 peptide antigen purified from bacteria and displayed in a high-density repetitive manner on a virus-like particle could generate anti-SARS-CoV-2 neutralizing antibodies unlike free peptide
Feroza Begum, Sreyashi Chandra, Md Hasan Mallik, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 739, pp. 150579-150579
Closed Access | Times Cited: 1
EpiScan: accurate high-throughput mapping of antibody-specific epitopes using sequence information
Chuan Wang, Jiangyuan Wang, Wenjun Song, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access | Times Cited: 1
Longitudinal analysis of B- and T-cell responses to SARS-CoV-2 recombinant S-protein vaccine S-268019-b in phase 1/2 priming and booster study
Masaya Fujitani, Xiuyuan Lu, Ryo Shinnakasu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Structural Immunology of SARS‐CoV‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 1
A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
Rong-Hong Hua, Shujian Zhang, Bei Lyu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 4
Immune targets to stop future SARS-CoV-2 variants
Milena Silva Souza, Jéssica Pires Farias, Wilson Barros Luiz, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 2
The Effect of SARS-CoV-2 Spike Protein RBD-Epitope on Immunometabolic State and Functional Performance of Cultured Primary Cardiomyocytes Subjected to Hypoxia and Reoxygenation
Vytenis Keturakis, Deimantė Narauskaitė, Zbigniev Balion, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16554-16554
Open Access | Times Cited: 2
A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants
Abhishek Chiyyeadu, Girmay Asgedom, Matthias Bruhn, et al.
Clinical Immunology (2024) Vol. 260, pp. 109902-109902
Open Access
Page 1 - Next Page

Scroll to top